Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Dren Bio (1)

Hiroshima University Hospital (1)

Collaborator

Novotech (1)

ProTrials Research Inc. (1)

Intervention

dr-01 (1)

ppmx-t003 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

aggressive nk cell leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)

Recruiting

Aggressive NK Cell Leukemia

PPMX-T003

Hiroshima, Japan

Hiroshima University Hospital

May 9, 2023

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting

LGLL - Large Granular Lymphocytic Leukemia
+13 more

DR-01

Duarte, California
+9 more

Aug 9, 2022